KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Non-Current Debt (2016 - 2025)

Ionis Pharmaceuticals has reported Non-Current Debt over the past 17 years, most recently at $28.1 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $28.1 million for Q4 2025, down 45.85% from a year ago — trailing twelve months through Dec 2025 was $28.1 million (down 45.85% YoY), and the annual figure for FY2025 was $28.1 million, down 45.85%.
  • Non-Current Debt for Q4 2025 was $28.1 million at Ionis Pharmaceuticals, down from $51.9 million in the prior quarter.
  • Over the last five years, Non-Current Debt for IONS hit a ceiling of $60.0 million in Q2 2021 and a floor of $8.8 million in Q1 2023.
  • Median Non-Current Debt over the past 5 years was $35.0 million (2023), compared with a mean of $38.2 million.
  • Biggest five-year swings in Non-Current Debt: soared 298.61% in 2021 and later plummeted 73.25% in 2022.
  • Ionis Pharmaceuticals' Non-Current Debt stood at $59.7 million in 2021, then plummeted by 73.25% to $16.0 million in 2022, then soared by 161.92% to $41.8 million in 2023, then rose by 24.11% to $51.9 million in 2024, then plummeted by 45.85% to $28.1 million in 2025.
  • The last three reported values for Non-Current Debt were $28.1 million (Q4 2025), $51.9 million (Q4 2024), and $41.8 million (Q4 2023) per Business Quant data.